Vaso Corporation/ US92233F1021 /
2024-03-28 8:30:14 PM | Chg. -0.0049 | Volume | Bid- | Ask- | High | Low |
---|---|---|---|---|---|---|
0.3001USD | -1.59% | 74,688 Turnover: 22,460.8568 |
-Bid Size: - | -Ask Size: - | 0.3070 | 0.3001 |
GlobeNewswire
2:00 AM
BLUE ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against...
GlobeNewswire
03-28
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors It Has Filed a Complaint to Recover Loss...
GlobeNewswire
03-28
BLUE INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that bluebird bio, Inc. Investors wi...
GlobeNewswire
03-07
AB Science provides a summary of the live webcast held on March 4, 2024 giving an update on AB Scien...
GlobeNewswire
02-27
Philips launches new Azurion neuro biplane system at #ECR2024 to speed up and improve minimally inva...
GlobeNewswire
02-13
European Commission Approves First CRISPR/Cas9 Gene-Edited Therapy, CASGEVY™ (exagamglogene autotemc...
GlobeNewswire
2023-12-11
Editas Medicine Announces New EDIT-301 Safety and Efficacy Data in 17 Patients, Presented Today at t...
GlobeNewswire
2023-12-11
RoslinCT to manufacture first-ever US FDA approved CRISPR-based gene therapy CASGEVY™ (exagamglogene...
GlobeNewswire
2023-11-27
AB Science: The clinical development of masitinib in sickle cell disease is among the 19 winning pro...
GlobeNewswire
2023-11-06
CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2023 Financial Results
GlobeNewswire
2023-11-02
Editas Medicine to Present Clinical Data from the RUBY and EdiTHAL Trials of EDIT-301 at the ASH 202...
GlobeNewswire
2023-10-31
CRISPR Therapeutics Announces Completion of FDA Advisory Committee Meeting for Exagamglogene Autotem...
GlobeNewswire
2023-10-31
CRISPR Therapeutics Trading Halted Today; FDA Advisory Committee to Review Biologics License Applica...
GlobeNewswire
2022-03-25
US Food and Drug Administration Revises Emergency Use Authorization for Sotrovimab Due to Omicron BA...
GlobeNewswire
2022-03-02
Nicox’s Partner Fera Pharmaceuticals Obtains Orphan Drug Designation from the U.S. FDA for Naproxcin...
GlobeNewswire
2022-02-24
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial ...
GlobeNewswire
2022-02-16
European Commission Approves Oxbryta® (voxelotor) for the Treatment of Hemolytic Anemia in Patients ...
GlobeNewswire
2022-02-14
Roivant Sciences Reports Financial Results for the Quarter Ended December 31, 2021 and Provides Busi...
GlobeNewswire
2022-02-10
Data Suggest Sotrovimab Retains Neutralizing Activity Against Omicron Subvariant BA.2
GlobeNewswire
2022-01-13
GSK and Vir Submit Emergency Use Authorization Application to FDA for Intramuscular Administration o...